Clinical Trial Update: Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating chlorhexidine gluconate topical skin application to prevent infection in infants weighing <1500 grams at birth was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Chlorhexidine gluconate topical (Chlorhexidine gluconate)

Snippet

Sponsor: All India Institute of Medical Sciences | Conditions: Neonatal Sepsis, Neonatal Mortality Rate | Phase 2, Phase 3 | Status: WITHDRAWN